Hepatobiliary and Pancreatic Function: Physiologic Changes

  • D. LaRon Mason
  • F. Charles Brunicardi


Normal variation in physiologic parameters of the hepatobiliary system and pancreas is increasingly recognized in the elderly. Appreciation of these alterations allows the surgeon to distinguish between expected physiologic variation and intercurrent pathophysiology in the clinical setting. It is with this goal in mind that we present this review of normal hepatobiliary and pancreatic physiology compared with recognized physiologic aging of these organ systems and select pathophysiology.


Bile Acid Bile Salt Pancreatic Polypeptide Gallstone Formation Pigment Stone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Klein AS, Lillemoe KD, Yeo CJ, Pitt HA. Liver, biliary tract, and pancreas. In: O’Leary JP (ed) The Physiologic Basis of Surgery, 2nd ed. Baltimore: Williams & Wilkins, 1996:441–478.Google Scholar
  2. 2.
    Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 1968; 47:1043–1052.PubMedCrossRefGoogle Scholar
  3. 3.
    Popper H. Aging and the liver. Prog Liver Dis 1986;8:659–683.PubMedGoogle Scholar
  4. 4.
    Mooney H, Roberts R, Cooksley WGE, et al. Alterations in the liver with aging. Clin Gastroenterol 1985;14:757–771.PubMedGoogle Scholar
  5. 5.
    Thompson EN, Williams R. Effect of age on liver function with particular reference to Bromsulphalein excretion. Gut 1965;6:266–269.PubMedCrossRefGoogle Scholar
  6. 6.
    Kampmann JP, Sinding J, Møller-Jørgensen I. Effect of age on liver function. Geriatrics 1975;30:91–95.PubMedGoogle Scholar
  7. 7.
    Rafsky HA, Newman B. Liver function tests in the aged (the serum cholesterol partition, Bromsulphalein, cephalin-flocculation and oral and intravenous hippuric acid tests). Am J Dig Dis 1943;10:66–69.CrossRefGoogle Scholar
  8. 8.
    Koff RS, Garvey AJ, Burney SW, et al. Absence of an age effect on sulfobromophthalein retention in healthy men. Gastroenterology 1973;65:300–302.PubMedGoogle Scholar
  9. 9.
    Qvist N. Motor activity of the gallbladder and gastrointestinal tract as determinants of enterohepatic circulation: a scintigraphic and manometric study. Dan Med Bull 1995;42:426–440.PubMedGoogle Scholar
  10. 10.
    Gadacz TR. Biliary anatomy and physiology. In: Greenfield LJ (ed) Surgery: Scientific Principles and Practice. Philadelphia: Lippincott, 1993:925–936.Google Scholar
  11. 11.
    Khalil T, Walker JP, Wiener I, et al. Effect of aging on gallbladder contraction and release of cholecystokinin-33 in humans. Surgery 1985;98:423–429.PubMedGoogle Scholar
  12. 12.
    Nagase M, Hikasa Y, Soloway RD, et al. Surgical significance of dilatation of the common bile duct: with special reference to choledocholithiasis. Jpn J Surg 1980;10:296–301.PubMedCrossRefGoogle Scholar
  13. 13.
    Valdivieso V, Palma R, Wünkhaus R, et al. Effect of aging on biliary lipid composition and bile acid metabolism in normal Chilean women. Gastroenterology 1978;74:871–874.PubMedGoogle Scholar
  14. 14.
    Bateson MC. Gallbladder disease and cholecystectomy rate are independently variable. Lancet 1984;2:621–624.PubMedCrossRefGoogle Scholar
  15. 15.
    Lieber MM. The incidence of gallstones and their correlation with other diseases. Ann Surg 1952;135:394–405.PubMedCrossRefGoogle Scholar
  16. 16.
    Lindström CG. Frequency of gallstone disease in a well-defined Swedish population. Scand J Gastroenterol 1977; 12:341–346.PubMedCrossRefGoogle Scholar
  17. 17.
    Marinovic I, Guerra C, Larach G. Incidencia de litiasis biliar en material de autopsias y analisis de composicion de los calculos. Rev Med Chil 1972;100:1320–1327.PubMedGoogle Scholar
  18. 18.
    Heaton KW. The epidemiology of gallstones and suggested aetiology. Clin Gastroenterol 1973;2:67–83.PubMedGoogle Scholar
  19. 19.
    National Center for Health Statistics. National Hospital Discharge Survey: Annual Summary, 1994. Series 13: Data from the National Health Care Survey, No. 128. DHHS Publ No. (PHS) 97–1789. Hyattsville, MD: National Center for Health Statistics, May 1997.Google Scholar
  20. 20.
    Reiss R, Deutsch AA. Emergency abdominal procedures in patients above 70. J Gerontol 1985;40:154–158.PubMedCrossRefGoogle Scholar
  21. 21.
    Tang WH. Serum and bile lipid levels in patients with and without gallstones. J Gastroenterol 1996;31:823–827.PubMedCrossRefGoogle Scholar
  22. 22.
    Holan KR, Holzbach RT, Hermann RE, et al. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979;77:611–617.PubMedGoogle Scholar
  23. 23.
    Portincasa P, Stolk MFJ, van Erpecum KJ, et al. Cholesterol gallstone formation in man and potential treatments of the gallbladder motility defect. Scand J Gastroenterol 1995;30(suppl 212):63–78.CrossRefGoogle Scholar
  24. 24.
    Patankar R, Ozmen MM, Bailey IS, Johnson CD. Gallbladder motility, gallstones, and the surgeon. Dig Dis Sci 1995;40:2323–2335.PubMedCrossRefGoogle Scholar
  25. 25.
    Schneider H, Sänger P, Hanisch E. In vitro effects of chole-cystokinin fragments on human gallbladders: evidence for an altered CCK-receptor structure in a subgroup of patients with gallstones. J Hepatol 1997;26:1063–1068.PubMedCrossRefGoogle Scholar
  26. 26.
    Thompson JC, Fried GM, Ogden WS, et al. Correlation between release of cholecystokinin and contraction of the gallbladder in patients with gallstones. Ann Surg 1982;195:670–676.PubMedCrossRefGoogle Scholar
  27. 27.
    Zhu XG, Greely GH, Newman J, et al. Correlation of in vitro measurements of contractility of the gallbladder with in vivo ultrasonographic findings in patients with gallstones. Surg Gynecol Obstet 1985;161:470–472.PubMedGoogle Scholar
  28. 28.
    Upp JR, Nealon WH, Singh P, et al. Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones. Ann Surg 1987;205:641–648.PubMedCrossRefGoogle Scholar
  29. 29.
    Einarsson K, Nilsell K, Leijd B, Angelin B. Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 1985;313:277–282.PubMedCrossRefGoogle Scholar
  30. 30.
    Bowen JC, Brenner HI, Ferrante WA, Maule WE Gallstone disease: pathophysiology, epidemiology, natural history, and treatment options. Med Clin North Am 1992;76:1143–1157.PubMedGoogle Scholar
  31. 31.
    Ahlberg J, Angelin B, Einarsson K. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment. J Lipid Res 1981;22:410–422.PubMedGoogle Scholar
  32. 32.
    Anderson DK, Brunicardi FC. Pancreatic anatomy and physiology. In: Greenfield LJ (ed) Surgery: Scientific Principles and Practice. Philadelphia: Lippincott, 1993:775–791.Google Scholar
  33. 33.
    DiMagno EP, Vay LWG, Summerskill WHJ. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973;288:813–815.PubMedCrossRefGoogle Scholar
  34. 34.
    Youngren JF, Goldfine ID. The molecular basis of insulin resistance. Sci Med 1997;4(3): 18–27.Google Scholar
  35. 35.
    Brunicardi FC, Chaiken RL, Ryan AS, et al. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab 1996;81:3566–3572.PubMedCrossRefGoogle Scholar
  36. 36.
    Seymour NE, Volpert AR, Lee EL, et al. Alterations in hepa-tocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide. Am J Surg 1995;169:105–110.PubMedCrossRefGoogle Scholar
  37. 37.
    Spector SA, Frattini JC, Zdankiewicz PD, et al. Insulin receptor gene expression in chronic pancreatitis: the effect of pancreatic polypeptide. In: Surgical Forum. Proceedings for the 52nd Annual Sessions of the Owen H. Wangensteen Surgical Forum; 1997 Oct 12–17; Chicago. Lawrence, KS: Allen Press, 1997:168–171.Google Scholar
  38. 38.
    Brunicardi FC, Druck P, Sun YS, et al. Regulation of pancreatic polypeptide secretion in the isolated perfused human pancreas. Am J Surg 1988;155:63–69.PubMedCrossRefGoogle Scholar
  39. 39.
    Kreel L, Sandin B. Changes in pancreatic morphology associated with aging. Gut 1973;14:962–970.PubMedCrossRefGoogle Scholar
  40. 40.
    Nagai H, Ohtsubo K. Pancreatic lithiasis in the aged. Gastroenterology 1984;86:331–338.PubMedGoogle Scholar
  41. 41.
    Laugier R, Sarles H. The pancreas. Clin Gastroenterol 1985;14:749–756.Google Scholar
  42. 42.
    Gullo L, Ventrucci M, Naldoni P, Pezzilli R. Aging and exocrine pancreatic function. J Am Geriatr Soc 1986;34:790–792.PubMedGoogle Scholar
  43. 43.
    Spence JC. Some observations on sugar tolerance, with special reference to variations found at different ages. Q J Med 1921;14:314–326.CrossRefGoogle Scholar
  44. 44.
    Davidson MB. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism 1979;28:688–705.PubMedCrossRefGoogle Scholar
  45. 45.
    Bennett PH. Diabetes in the elderly: diagnosis and epidemiology. Geriatrics 1984;39:37–41.PubMedGoogle Scholar
  46. 46.
    Taylor R, Agius L. The biochemistry of diabetes. Biochem J 1988;250:625–640.PubMedGoogle Scholar
  47. 47.
    Berger D, Crowther RC, Floyd JC Jr, et al. Effect of age on fasting plasma levels of pancreatic hormones in man. J Clin Endocrinol Metab 1978;47:1183–1189.PubMedCrossRefGoogle Scholar
  48. 48.
    Timiras PS. The endocrine pancreas and carbohydrate metabolism. In: Timiras PS (ed) Physiological Basis of Aging and Geriatrics, 2nd ed. Boca Raton, FL: CRC Press, 1994:191–197.Google Scholar
  49. 49.
    Goldfine ID. The insulin receptor: molecular biology and transmembrane signaling. Endocr Rev 1987;8:235–255.PubMedCrossRefGoogle Scholar
  50. 50.
    Simonson DC, DeFronzo RA. Glucagon physiology and aging: evidence for enhanced hepatic sensitivity. Diabetologia 1983;25:1–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • D. LaRon Mason
  • F. Charles Brunicardi

There are no affiliations available

Personalised recommendations